Back to Search
Start Over
Mycophenolate Improves Brain–Gut Axis Inducing Remodeling of Gut Microbiota in DOCA-Salt Hypertensive Rats
- Source :
- Digibug: Repositorio Institucional de la Universidad de Granada, Universidad de Granada (UGR), Antioxidants, Volume 9, Issue 12, Digibug. Repositorio Institucional de la Universidad de Granada, instname, Repisalud, Instituto de Salud Carlos III (ISCIII), Antioxidants, Vol 9, Iss 1199, p 1199 (2020)
- Publication Year :
- 2020
- Publisher :
- Mdpi, 2020.
-
Abstract
- Microbiota is involved in the host blood pressure (BP) regulation. The immunosuppressive drug mofetil mycophenolate (MMF) ameliorates hypertension. The present study analyzed whether MMF improves dysbiosis in mineralocorticoid-induced hypertension. MaleWistar rats were assigned to three groups: untreated (CTR), deoxycorticosterone acetate (DOCA)-salt, and DOCA treated with MMF for 4 weeks. MMF treatment reduced systolic BP, improved endothelial dysfunction, and reduced oxidative stress and inflammation in aorta. A clear separation in the gut bacterial community between CTR andDOCAgroups was found, whereas the cluster belonging toDOCA-MMF group was found to be intermixed. No changes were found at the phylum level among all experimental groups. MMF restored the elevation in lactate-producing bacteria found in DOCA-salt joined to an increase in the acetate-producing bacteria. MMF restored the percentage of anaerobic bacteria in the DOCA-salt group to values similar to control rats. The improvement of gut dysbiosis was associated with an enhanced colonic integrity and a decreased sympathetic drive in the gut. MMF inhibited neuroinflammation in the paraventricular nuclei in the hypothalamus. This study demonstrates for the first time that MMF reduces gut dysbiosis in DOCA-salt hypertension models. This e ect seems to be related to its capacity to improve gut integrity due to reduced sympathetic drive in the gut associated with reduced brain neuroinflammation.<br />Comisión Interministerial de Ciencia y Tecnología, Ministerio de Economía y competitividad SAF2017-84894-R<br />Junta de Andalucía CTS-164<br />European Union (EU)<br />Ministerio de Economía y Competitividad, Instituto de Salud Carlos III (CIBER-CV), Spain<br />United States Department of Health & Human Services National Institutes of Health (NIH) - USA NIH National Heart Lung & Blood Institute (NHLBI) HL102033<br />European Union (Fondo Europeo de Desarrollo Regional, FEDER, "FEDER una manera de hacer Europa")
- Subjects :
- 0301 basic medicine
Physiology
Clinical Biochemistry
mycophenolate, gut dysbiosis, hypertension, oxidative stress, inflammation, (deoxycorticosterone acetate) DOCA-salt model
(Deoxycorticosterone acetate) DOCA-salt model
030204 cardiovascular system & hematology
Gut flora
medicine.disease_cause
Biochemistry
Anatomy::Cardiovascular System::Blood Vessels::Arteries::Aorta [Medical Subject Headings]
Gut dysbiosis
0302 clinical medicine
Organisms::Eukaryota::Animals [Medical Subject Headings]
oxidative stress
Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Rats::Rats, Wistar [Medical Subject Headings]
Endothelial dysfunction
mycophenolate
biology
Microbiota
Estrés oxidativo
Organisms::Bacteria::Bacteria, Anaerobic [Medical Subject Headings]
Phenomena and Processes::Microbiological Phenomena::Microbiota [Medical Subject Headings]
Hypertension
Diseases::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Dysbiosis [Medical Subject Headings]
Anaerobic bacteria
medicine.symptom
hormones, hormone substitutes, and hormone antagonists
medicine.medical_specialty
hypertension
Chemicals and Drugs::Organic Chemicals::Carboxylic Acids::Acids, Acyclic::Acetates [Medical Subject Headings]
Check Tags::Male [Medical Subject Headings]
Inflammation
Acetato de desoxicorticosterona
Article
Diseases::Cardiovascular Diseases::Vascular Diseases::Hypertension [Medical Subject Headings]
Phenomena and Processes::Physiological Phenomena::Physiological Processes::Stress, Physiological::Oxidative Stress [Medical Subject Headings]
03 medical and health sciences
gut dysbiosis
Internal medicine
Hipertensión
Phenomena and Processes::Circulatory and Respiratory Physiological Phenomena::Cardiovascular Physiological Phenomena::Hemodynamics::Blood Pressure [Medical Subject Headings]
medicine
Mycophenolate
Molecular Biology
Neuroinflammation
Inflamación
Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Mineralocorticoids [Medical Subject Headings]
business.industry
lcsh:RM1-950
(deoxycorticosterone acetate) DOCA-salt model
Anatomy::Nervous System::Central Nervous System::Brain [Medical Subject Headings]
Chemicals and Drugs::Organic Chemicals::Carboxylic Acids::Hydroxy Acids::Lactates::Lactic Acid [Medical Subject Headings]
Cell Biology
Anatomy::Nervous System::Central Nervous System::Brain::Limbic System::Hypothalamus [Medical Subject Headings]
medicine.disease
biology.organism_classification
lcsh:Therapeutics. Pharmacology
030104 developmental biology
Endocrinology
Blood pressure
inflammation
Oxidative stress
business
Dysbiosis
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Digibug: Repositorio Institucional de la Universidad de Granada, Universidad de Granada (UGR), Antioxidants, Volume 9, Issue 12, Digibug. Repositorio Institucional de la Universidad de Granada, instname, Repisalud, Instituto de Salud Carlos III (ISCIII), Antioxidants, Vol 9, Iss 1199, p 1199 (2020)
- Accession number :
- edsair.doi.dedup.....9e5a0c03c4322ff174fcf31ce3ac6495
- Full Text :
- https://doi.org/10.3390/antiox9121199